62062 Federal Register / Vol. 62, No. 224 / Thursday, November 20, 1997 / Notices

Dated: November 13, 1997.

Carolyn J. Russell,

Director, Management Analysis and Services

Office, Centers for Disease Control and

Prevention (CDC).

[FR Doc. 97–30475 Filed 11–19–97; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Advisory Committee for EnergyRelated Epidemiologic Research;

Meeting

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Centers for Disease

Control and Prevention (CDC)

announces the following committee

meeting.

Name: Advisory Committee for EnergyRelated Epidemiologic Research.

Times and Dates: 9 a.m.–5 p.m., December

8, 1997; 9 a.m.–12 noon, December 9, 1997.

Place: Hyatt Regency Crystal City, 2799

Jefferson Davis Highway, Arlington, Virginia

22202, telephone 703/418–1234, FAX 703/

418–1289.

Status: Open to the public, limited only by

the space available. The meeting room

accommodates approximately 50 people.

Purpose: This committee is charged with

providing advice and recommendations to

the Secretary; the Assistant Secretary for

Health; the Director, CDC; and the

Administrator, Agency for Toxic Substances

and Disease Registry (ATSDR), on

establishment of a research agenda and the

conduct of a research program pertaining to

energy-related analytic epidemiologic

studies.

Matters to be Discussed: Agenda items will

include: presentations from the National

Center for Environmental Health (NCEH), the

National Institute for Occupational Safety

and Health, and ATSDR updates on the

progress of current studies; a discussion of

Work Group recommendations, and public

involvement activities.

Agenda items are subject to change as

priorities dictate.

CONTACT PERSON FOR MORE INFORMATION:

Michael J. Sage, Deputy Chief, Radiation

Studies Branch, Division of

Environmental Hazards and Health

Effects, NCEH, CDC, 4770 Buford

Highway, NE, (F–35), Atlanta, Georgia

30341–3724, telephone 770/488–7040,

FAX 770/488–7044.

Dated: November 13, 1997.

Carolyn J. Russell,

Director, Management Analysis and Services

Office Centers for Disease Control and

Prevention (CDC).

[FR Doc. 97–30476 Filed 11–19–97; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention (CDC)

The National Center for Environmental

Health (NCEH) of the Centers for

Disease Control and Prevention (CDC);

Cancellation of Meeting

This notice announces the

cancellation of a previously announced

meeting: Workshop on Screening and

Tracking Systems for Early Hearing

Detection and Intervention (EHDI).

Federal Register Notice Citation of

Previous Announcement: FR Doc.

17oc97–115. Published October 17,

1997 (Volume 62, Number 200, Page

54116).

Previously Announced Times and

Dates: 8 a.m.–5 p.m. December 11, 1997.

8:30 a.m.–1 p.m. December 12, 1997.

Change in the Meeting: This meeting

has been canceled.

CONTACT PERSON FOR MORE INFORMATION:

June Holstrum, Ph.D., Division of Birth

Defects and Developmental Disabilities,

CDC, NCEH, 4770 Buford Highway, NE,

M/S F–15, Atlanta, Georgia 30341. Email ehdi@cdc.gov, telephone 770/488–

7401, fax 770/488–7361.

Dated: November 13, 1997.

Carolyn J. Russell,

Director, Management Analysis and Services

Office Centers for Disease Control and

Prevention (CDC).

[FR Doc. 97–30480 Filed 11–19–97; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

[Docket No. 97F–0428]

Amoco Corp.; Filing of Food Additive

Petition

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing

that Amoco Corp. has filed a petition

proposing that the food additive

regulations be amended to include

dimethyl-2,6-naphthalene dicarboxylate

and 2,6-naphthalene dicarboxylic acid

as polybasic acids intended for use as

components of resinous and polymeric

coatings that contact food.

FOR FURTHER INFORMATION CONTACT:

Mark A. Hepp, Center for Food Safety

and Applied Nutrition (HFS–215), Food

and Drug Administration, 200 C St. SW.,

Washington, DC 20204, 202–418–3098.

SUPPLEMENTARY INFORMATION: Under the

Federal Food, Drug, and Cosmetic Act

(sec. 409(b)(5) (21 U.S.C. 348(b)(5))),

notice is given that a food additive

petition (FAP 7B4555) has been filed by

Amoco Corp., One Prudential Plaza, 130

East Randolph St., Chicago, IL 60601–

6207. The petition proposes to amend

the food additive regulations in

§ 175.300 Resinous and polymeric

coatings (21 CFR 175.300) to include

dimethyl-2,6-naphthalene dicarboxylate

and 2,6-naphthalene dicarboxylic acid

as polybasic acids intended for use as

components of resinous and polymeric

coatings that contact food.

The agency has determined under 21

CFR 25.32(i) and (j) that this action is of

a type that does not individually or

cumulatively have a significant effect on

the human environment. Therefore,

neither an environmental assessment

nor an environmental impact statement

is required.

Dated: October 21, 1997.

Alan M. Rulis,

Director, Office of Premarket Approval,

Center for Food Safety and Applied Nutrition.

[FR Doc. 97–30481 Filed 11–19–97; 8:45 am]

BILLING CODE 4160–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food And Drug Administration

[Docket No. 97F–0469]

General Electric Co.; Filing of Food

Additive Petition

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing

that General Electric Co. has filed a

petition proposing that the food additive

regulations be amended to provide for

the expanded safe use of phosphorous

acid, cyclic butylethyl propanediol,

2,4,6-tri-tert-butylphenyl ester, which

may contain up to 1 percent by weight

of triisopropanolamine, as an

antioxidant and/or stabilizer in high

density polyethylene and high density

olefin copolymers intended for use in

contact with food.

FOR FURTHER INFORMATION CONTACT: Vir

D. Anand, Center for Food Safety and

Applied Nutrition (HFS–216), Food and

Drug Administration, 200 C St. SW.,

Washington, DC 20204, 202–418–3081.

SUPPLEMENTARY INFORMATION: Under the

Federal Food, Drug, and Cosmetic Act